Actavis Can't Escape Testosterone Drug Warning Claims
An Illinois federal judge won't give Actavis Inc. a quick win on claims that one of its testosterone drugs led to a user's stroke, finding that the company's duty to warn...To view the full article, register now.
Already a subscriber? Click here to view full article